These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 7779583)

  • 1. New anticancer agents.
    Weiss GR; Burris HA; Eckardt JR; Fields S; O'Rourke T; Rodriguez GI; Rothenberg ML
    Cancer Chemother Biol Response Modif; 1994; 15():130-51. PubMed ID: 7779583
    [No Abstract]   [Full Text] [Related]  

  • 2. 2,2,2-Trichloro-N-({2-[2-(dimethylamino)ethyl]-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin- 5-yl}carbamoyl)acetamide (UNBS3157), a novel nonhematotoxic naphthalimide derivative with potent antitumor activity.
    Van Quaquebeke E; Mahieu T; Dumont P; Dewelle J; Ribaucour F; Simon G; Sauvage S; Gaussin JF; Tuti J; El Yazidi M; Van Vynckt F; Mijatovic T; Lefranc F; Darro F; Kiss R
    J Med Chem; 2007 Aug; 50(17):4122-34. PubMed ID: 17658777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Developed new agents for lung cancer].
    Kato Y; Saijo N
    Nihon Geka Gakkai Zasshi; 2002 Feb; 103(2):218-23. PubMed ID: 11904983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of cell kill kinetics of anticancer agents using the collagen gel droplet embedded-culture drug sensitivity test.
    Mori T; Ohnishi M; Komiyama M; Tsutsui A; Yabushita H; Okada H
    Oncol Rep; 2002; 9(2):301-5. PubMed ID: 11836596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential activity of paclitaxel, vinorelbine and gemcitabine in anaplastic thyroid carcinoma.
    Voigt W; Kegel T; Weiss M; Mueller T; Simon H; Schmoll HJ
    J Cancer Res Clin Oncol; 2005 Sep; 131(9):585-90. PubMed ID: 16021466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics of anticancer agents: lessons from amonafide and irinotecan.
    Innocenti F; Iyer L; Ratain MJ
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 2):596-600. PubMed ID: 11259359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment.
    Meert AP; Berghmans T; Branle F; Lemaître F; Mascaux C; Rubesova E; Vermylen P; Paesmans M; Sculier JP
    Anticancer Res; 1999; 19(5C):4379-90. PubMed ID: 10650780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New chemotherapeutic agents for non-small cell lung cancer.
    Miller VA; Rigas JR; Grant SC; Pisters KM; Kris MG
    Chest; 1995 Jun; 107(6 Suppl):306S-311S. PubMed ID: 7781411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lung cancer].
    Furuse K
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1917-24. PubMed ID: 9350236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New anti-cancer agents--from cytotoxic systemic chemotherapy to target-based agents].
    Yokoba M; Yanase N; Masuda N
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):783-8. PubMed ID: 15984516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive small-cell lung cancer: a treatment overview.
    Sandler A
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 5):49-55. PubMed ID: 10981291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New drug for therapy of non-small cell lung cancer.
    Klastersky J
    Lung Cancer; 1994 Nov; 11 Suppl 3():S139-49. PubMed ID: 7704506
    [No Abstract]   [Full Text] [Related]  

  • 13. [New therapeutic approaches in non-small-cell lung carcinoma (NSCLC), stages IV].
    Mavroudis D
    Rev Pneumol Clin; 2001 Nov; 57(5 Pt 2):S42-5. PubMed ID: 11924243
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer.
    Han JY; Lee DH; Song JE; Lee SY; Kim HY; Kim HT; Lee JS
    Cancer; 2008 Jul; 113(2):388-95. PubMed ID: 18484595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New drugs in gastrointestinal oncology. Current status and future directions].
    Conroy T; Paillot B; Adenis A
    Gastroenterol Clin Biol; 1999 Nov; 23(11):1145-65. PubMed ID: 10651534
    [No Abstract]   [Full Text] [Related]  

  • 16. Topoisomerase I inhibitors combination chemotherapy in non-small cell lung cancer.
    Tumolo S; Toffoli G; Saracchini S; Lo Re G; Bruschi G; Boccieri MG
    Lung Cancer; 2001 Dec; 34 Suppl 4():S37-46. PubMed ID: 11742701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-platinum based combination chemotherapy: phase I and II trials of docetaxel plus gemcitabine, vinorelbine, or irinotecan.
    Rigas JR
    Semin Oncol; 2001 Jun; 28(3 Suppl 9):15-20. PubMed ID: 11441410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New chemotherapy agents for small cell lung cancer.
    Kelly K
    Chest; 2000 Apr; 117(4 Suppl 1):156S-162S. PubMed ID: 10777472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in cancer therapy.
    Mercado I; Baez L; Caceres W
    Bol Asoc Med P R; 1997; 89(7-9):120-6. PubMed ID: 9419930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New promising anticancer drugs for lung cancer].
    Ariyoshi Y; Sugiura T
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2578-84. PubMed ID: 7979416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.